{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":5,"total":127,"mapped":4},"pagination":{"has_next":true,"next_token":"-1[]O60674,1,O60674,59,1]["},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"Q5VWK5","source":"Q5VWK5|Interleukin-23 receptor","targets":["5MZV|IL-23:IL-23R:Nb22E11 complex|X-RAY DIFFRACTION|2.8|Homo sapiens; Lama glama|0|CYTOKINE","6WDQ|IL23/IL23R/IL12Rb1 signaling complex|X-RAY DIFFRACTION|3.4|Homo sapiens|0|SIGNALING PROTEIN","8OE4|Cryo-EM structure of a pre-dimerized human IL-23 complete extracellular signaling complex.|ELECTRON MICROSCOPY|3.6|Homo sapiens|0|SIGNALING PROTEIN","9MFG|Complex of IL23 receptor and VHH|X-RAY DIFFRACTION|2.85|Homo sapiens; Lama glama|0|IMMUNE SYSTEM"]},{"input":"Q9H257","source":"Q9H257|Caspase recruitment domain-containing protein 9","targets":["6E25|NMR solution structure of the CARD9 CARD bound to zinc|SOLUTION NMR||Homo sapiens|0|SIGNALING PROTEIN","6E26|NMR solution structure of the CARD9 CARD|SOLUTION NMR||Homo sapiens|0|SIGNALING PROTEIN","6E27|The CARD9 CARD domain-swapped dimer with a zinc ion bound to one of the two zinc binding sites|X-RAY DIFFRACTION|1.811|Homo sapiens|0|SIGNALING PROTEIN","6E28|The CARD9 CARD domain-swapped dimer|X-RAY DIFFRACTION|1.36|Homo sapiens|0|SIGNALING PROTEIN","6N2M|NMR solution structure of the homodimeric, autoinhibited state of the CARD9 CARD and first coiled-coil|SOLUTION NMR||Homo sapiens|0|SIGNALING PROTEIN","6N2P|Helical assembly of the CARD9 CARD|ELECTRON MICROSCOPY|4.0|Homo sapiens|0|SIGNALING PROTEIN","9AVM|Crystal Structure of CARD9 coiled-coil K156-K214|X-RAY DIFFRACTION|1.79|Homo sapiens|0|IMMUNE SYSTEM","9AVN|Crystal Structure of CARD9 coiled-coil K156-K214 bound to Compound 1|X-RAY DIFFRACTION|2.726|Homo sapiens|0|IMMUNE SYSTEM"]},{"input":"Q676U5","source":"Q676U5|Autophagy-related protein 16-1","targets":["4GDK|Crystal Structure of Human Atg12~Atg5 Conjugate in Complex with an N-terminal Fragment of Atg16L1|X-RAY DIFFRACTION|2.7|Homo sapiens|0|PROTEIN BINDING","4GDL|Crystal Structure of Human Atg12~Atg5 Conjugate in Complex with an N-terminal Fragment of Atg16L1|X-RAY DIFFRACTION|2.875|Homo sapiens|0|PROTEIN BINDING","4NAW|Crystal Structure of Human ATG12~ATG5-ATG16N in complex with a fragment of ATG3|X-RAY DIFFRACTION|2.195|Homo sapiens|0|PROTEIN TRANSPORT/LIGASE","4TQ0|Crystal structure of human ATG5-ATG16N69|X-RAY DIFFRACTION|2.697|Homo sapiens|0|PROTEIN BINDING","5D7G|Structure of human ATG5 E122D-ATG16L1 complex at 3.0 Angstroms|X-RAY DIFFRACTION|3|Homo sapiens|0|APOPTOSIS","5NPV|Structure of human ATG5-ATG16L1(ATG5BD) complex (I4)|X-RAY DIFFRACTION|3.1|Homo sapiens|0|CELL CYCLE","5NPW|Structure of human ATG5-ATG16L1(ATG5BD) complex (C2)|X-RAY DIFFRACTION|3.1|Homo sapiens|0|CELL CYCLE","5NUV|Structure of the WD40-domain of human ATG16L1|X-RAY DIFFRACTION|1.55|Homo sapiens|0|PROTEIN BINDING","5ZYX|Solution NMR structure of K30 peptide in 10 mM dioctanoyl phosphatidylglycerol (D8PG)|SOLUTION NMR|||0|ANTIMICROBIAL PROTEIN","7F69|Crystal structure of WIPI2b in complex with ATG16L1|X-RAY DIFFRACTION|1.5|Homo sapiens|0|PROTEIN BINDING","7W36|Crystal structure of human Atg5 complexed with a stapled peptide|X-RAY DIFFRACTION|3|Homo sapiens; SYNTHETIC CONSTRUCT|0|LIGASE","7XFR|Crystal structure of WIPI2b in complex with the second site of ATG16L1|X-RAY DIFFRACTION|1.76|Homo sapiens|0|PROTEIN BINDING","8ZQG|Crystal structure of WIPI3 in complex with ATG16L1|X-RAY DIFFRACTION|2.77|Homo sapiens|0|PROTEIN BINDING","9JF2|Crystal structure of GABARAPL1 in complex with ATG16L1|X-RAY DIFFRACTION|1.76|Homo sapiens; SYNTHETIC CONSTRUCT|0|PROTEIN BINDING","9J54|Crystal structure of FIP200 Claw in complex with ATG16L1|X-RAY DIFFRACTION|1.61|Homo sapiens|0|PROTEIN BINDING"]},{"input":"O60674","source":"O60674|Tyrosine-protein kinase JAK2","targets":["2B7A|The structural basis of Janus Kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSFERASE","2W1I|Structure determination of Aurora Kinase in complex with inhibitor|X-RAY DIFFRACTION|2.6|HOMO SAPIENS|0|TRANSFERASE","2XA4|Inhibitors of Jak2 Kinase domain|X-RAY DIFFRACTION|2.04|Homo sapiens|0|TRANSFERASE","3E62|Fragment based discovery of JAK-2 inhibitors|X-RAY DIFFRACTION|1.922|Homo sapiens|0|TRANSFERASE","3E63|Fragment based discovery of JAK-2 inhibitors|X-RAY DIFFRACTION|1.9|Homo sapiens|0|TRANSFERASE","3E64|Fragment based discovery of JAK-2 inhibitors|X-RAY DIFFRACTION|1.8|Homo sapiens|0|TRANSFERASE","3FUP|Crystal structures of JAK1 and JAK2 inhibitor complexes|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSFERASE","3IO7|2-Aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of JAK2|X-RAY DIFFRACTION|2.6|Homo sapiens|0|TRANSFERASE","3IOK|2-Aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of JAK2|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSFERASE","3JY9|Janus Kinase 2 Inhibitors|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSFERASE","3KCK|A Novel Chemotype of Kinase Inhibitors|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE","3KRR|Crystal Structure of JAK2 complexed with a potent quinoxaline ATP site inhibitor|X-RAY DIFFRACTION|1.8|Homo sapiens|0|TRANSFERASE","3LPB|Crystal structure of Jak2 complexed with a potent 2,8-diaryl-quinoxaline inhibitor|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSFERASE","3Q32|Structure of Janus kinase 2 with a pyrrolotriazine inhibitor|X-RAY DIFFRACTION|2.5|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3RVG|Crystals structure of Jak2 with a 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitor|X-RAY DIFFRACTION|2.498|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3TJC|Co-crystal structure of jak2 with thienopyridine 8|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3TJD|co-crystal structure of Jak2 with thienopyridine 19|X-RAY DIFFRACTION|2.9|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3UGC|Structural basis of Jak2 inhibition by the type II inhibtor NVP-BBT594|X-RAY DIFFRACTION|1.34|Homo sapiens|0|Transferase/transferase inhibitor","3ZMM|Inhibitors of Jak2 Kinase domain|X-RAY DIFFRACTION|2.51|HOMO SAPIENS|0|TRANSFERASE","4AQC|Triazolopyridine-based Inhibitor of Janus Kinase 2|X-RAY DIFFRACTION|1.9|HOMO SAPIENS|0|TRANSFERASE","4BBE|Aminoalkylpyrimidine Inhibitor Complexes with JAK2|X-RAY DIFFRACTION|1.9|HOMO SAPIENS|0|TRANSFERASE","4BBF|Aminoalkylpyrimidine Inhibitor Complexes with JAK2|X-RAY DIFFRACTION|2|HOMO SAPIENS|0|TRANSFERASE","4C61|Inhibitors of Jak2 Kinase domain|X-RAY DIFFRACTION|2.45|HOMO SAPIENS|0|TRANSFERASE","4C62|Inhibitors of Jak2 Kinase domain|X-RAY DIFFRACTION|2.75|HOMO SAPIENS|0|TRANSFERASE","4D0W|Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors|X-RAY DIFFRACTION|1.77|HOMO SAPIENS|0|TRANSFERASE","4D0X|Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors|X-RAY DIFFRACTION|1.82|HOMO SAPIENS|0|TRANSFERASE","4D1S|Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors|X-RAY DIFFRACTION|1.66|HOMO SAPIENS|0|TRANSFERASE","4E4M|JAK2 kinase (JH1 domain) in complex with compound 30|X-RAY DIFFRACTION|2.25|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4E6D|JAK2 kinase (JH1 domain) triple mutant in complex with compound 7|X-RAY DIFFRACTION|2.22|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4E6Q|JAK2 kinase (JH1 domain) triple mutant in complex with compound 12|X-RAY DIFFRACTION|1.948|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4F08|Discovery and Optimization of C-2 Methyl Imidazo-pyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2|X-RAY DIFFRACTION|2.82|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4F09|Discovery and Optimization of C-2 Methyl Imidazo-pyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4FVP|Crystal structure of the Jak2 pseudokinase domain (apo form)|X-RAY DIFFRACTION|2.01|Homo sapiens|0|TRANSFERASE","4FVQ|Crystal structure of the Jak2 pseudokinase domain (Mg-ATP-bound form)|X-RAY DIFFRACTION|1.75|Homo sapiens|0|TRANSFERASE","4FVR|Crystal structure of the Jak2 pseudokinase domain mutant V617F (Mg-ATP-bound form)|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSFERASE","4GFM|JAK2 kinase (JH1 domain) with 2,6-DICHLORO-N-(2-OXO-2,5-DIHYDROPYRIDIN-4-YL)BENZAMIDE|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4GMY|JAK2 kinase (JH1 domain) in complex with 2,6-DICHLORO-N-{2-[(CYCLOPROPYLCARBONYL)AMINO]PYRIDIN-4-YL}BENZAMIDE|X-RAY DIFFRACTION|2.403|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4HGE|JAK2 kinase (JH1 domain) in complex with compound 8|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4IVA|JAK2 kinase (JH1 domain) in complex with the inhibitor TRANS-4-[(8AS)-2-[(1R)-1-HYDROXYETHYL]IMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-1(8AH)-YL]CYCLOHEXANECARBONITRILE|X-RAY DIFFRACTION|1.5|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4JI9|JAK2 kinase (JH1 domain) in complex with TG101209|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4JIA|JAK2 kinase (JH1 domain) in complex with compound 9|X-RAY DIFFRACTION|1.85|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4P7E|Triazolopyridine compounds as selective JAK1 inhibitors: from hit identification to GLPG0634|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSFERASE","4YTC|Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Disease|X-RAY DIFFRACTION|2.16|Homo sapiens|0|Transferase/Transferase Inhibitor","4YTF|Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Diseases|X-RAY DIFFRACTION|1.78|Homo sapiens|0|Transferase/Transferase Inhibitor","4YTH|Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Diseases|X-RAY DIFFRACTION|2.04|Homo sapiens|0|Transferase/Transferase Inhibitor","4YTI|Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Disease|X-RAY DIFFRACTION|2.52|Homo sapiens|0|Transferase/Transferase Inhibitor","4Z32|Crystal Structure of the FERM-SH2 Domains of Jak2|X-RAY DIFFRACTION|3.04|Homo sapiens|0|TRANSFERASE","4ZIM|CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH A 9H-CARBAZOLE-1-CARBOXAMIDE INHIBITOR|X-RAY DIFFRACTION|2.65|Homo sapiens|0|Transferase/Transferase Inhibitor","5AEP|Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders|X-RAY DIFFRACTION|1.95|HOMO SAPIENS|0|TRANSFERASE","5CF4|CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL-10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-3,5,8,10-TETRAAZATRICYCLO[7.3.0.0,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11-CARBOXAMIDE|X-RAY DIFFRACTION|2.38|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5CF5|CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL-7-[(DIMETHYL-1,3-THIAZOL-2-YL)AMINO]-10-ETHYL-3-METHYL-3,5,8,10-TETRAAZATRICYCLO[7.3.0.02,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11-CARBOXAMIDE|X-RAY DIFFRACTION|2.45|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5CF6|CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL-10-[(2S)-2,3-DIHYDROXYPROPYL]-3-METHYL-7-(METHYLAMINO)-3,5,8,10-TETRAAZATRICYCLO [7.3.0.02,6]DODECA-1(9),2(6),4,7,11-PENTAENE-11-CARBOXAMIDE|X-RAY DIFFRACTION|2.5|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5CF8|CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL-10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-3,5,8,10-TETRAAZATRICYCLO[7.3.0.0,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11-CARBOXAMIDE|X-RAY DIFFRACTION|1.8|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5HEZ|JAK2 kinase (JH1 domain) mutant P1057A in complex with TG101209|X-RAY DIFFRACTION|2.66|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5I4N|Crystal Structure of the E596A V617F Mutant JAK2 Pseudokinase Domain Bound to Mg-ATP|X-RAY DIFFRACTION|1.54|Homo sapiens|0|TRANSFERASE","5L3A|Fragment-based discovery of 6-arylindazole JAK inhibitors|X-RAY DIFFRACTION|1.98|Homo sapiens|0|TRANSFERASE","5TQ3|Design and Synthesis of a pan-JAK kinase inhibitor clinical candidate (PF-06263276) suitable for the treatment of inflammatory diseases of the lungs and skin|X-RAY DIFFRACTION|2.69|Homo sapiens|0|Transferase/Transferase Inhibitor","5TQ4|Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin|X-RAY DIFFRACTION|2.3|Homo sapiens|0|Transferase/Transferase Inhibitor","5TQ5|Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin|X-RAY DIFFRACTION|2.3|Homo sapiens|0|Transferase/Transferase Inhibitor","5TQ6|Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin|X-RAY DIFFRACTION|2.06|Homo sapiens|0|Transferase/Transferase Inhibitor","5TQ7|Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin|X-RAY DIFFRACTION|2.1|Homo sapiens|0|Transferase/Transferase Inhibitor","5TQ8|Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin|X-RAY DIFFRACTION|1.59|Homo sapiens|0|Transferase/Transferase Inhibitor","5USY|JAK2 JH1 in complex with JNJ-7706621|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5USZ|JAK2 JH2 in complex with JNJ-7706621|X-RAY DIFFRACTION|2.103|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5UT0|JAK2 JH2 in complex with AT9283|X-RAY DIFFRACTION|2.102|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5UT1|JAK2 JH2 in complex with BI-D1870|X-RAY DIFFRACTION|1.95|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5UT2|JAK2 JH2 in complex with PRT062607|X-RAY DIFFRACTION|1.75|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5UT3|JAK2 JH2 in complex with IKK-2 Inhibitor VI|X-RAY DIFFRACTION|1.501|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5UT4|JAK2 JH2 in complex with NVP-BSK805|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5UT5|JAK2 JH2 in complex with GLPG0634|X-RAY DIFFRACTION|1.9|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5UT6|JAK2 JH2 in complex with a diaminopyrimidine|X-RAY DIFFRACTION|1.645|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5WEV|Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model|X-RAY DIFFRACTION|1.854|Homo sapiens|0|Transferase/Transferase Inhibitor","5WIJ|JAK2 Pseudokinase in complex with NU6140|X-RAY DIFFRACTION|2.04|Homo sapiens|0|TRANSFERASE","5WIK|JAK2 Pseudokinase in complex with BI-D1870|X-RAY DIFFRACTION|2.6|Homo sapiens|0|TRANSFERASE","5WIL|JAK2 Pseudokinase in complex with AZD7762|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE","5WIM|JAK2 Pseudokinase in complex with AT9283|X-RAY DIFFRACTION|2.55|Homo sapiens|0|TRANSFERASE","5WIN|JAK2 Pseudokinase in complex with JNJ7706621|X-RAY DIFFRACTION|2.38|Homo sapiens|0|TRANSFERASE","6AAJ|Crystal structure of JAK2 in complex with peficitinib|X-RAY DIFFRACTION|2.37|Homo sapiens|0|TRANSFERASE/INHIBITOR","6BBV|Crystal Structure of JAK2 in complex with compound 25|X-RAY DIFFRACTION|1.8|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","6BRW|JAK2 JH2 in complex with XMU-MP-1|X-RAY DIFFRACTION|2.031|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","6BS0|JAK2 JH2 in complex with 63552444|X-RAY DIFFRACTION|1.541|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","6BSS|JAK2 JH2 in complex with NU6102|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","6D2I|JAK2 Pseudokinase V617F in complex with AT9283|X-RAY DIFFRACTION|3.192|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","6DRW|JAK2 JH1 in complex with JNJ-7706621 (Crystal Form 2)|X-RAY DIFFRACTION|2.303|Homo sapiens|0|TRANSFERASE/TRANSFERASE Inhibitor","6E2P|Structure of human JAK2 FERM/SH2 in complex with Leptin Receptor|X-RAY DIFFRACTION|2.83|Homo sapiens|0|SIGNALING PROTEIN","6E2Q|Structure of human JAK2 FERM/SH2 in complex with Erythropoietin Receptor|X-RAY DIFFRACTION|2.65|Homo sapiens|0|SIGNALING PROTEIN","6G3C|Crystal Structure of JAK2-V617F pseudokinase domain in complex with Compound 2|X-RAY DIFFRACTION|1.6|Homo sapiens|0|TRANSFERASE","6M9H|JAK2 JH2 in complex with diaminopyrimidine JAK040|X-RAY DIFFRACTION|1.79|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","6OAV|JAK2 JH2 in complex with JAK146|X-RAY DIFFRACTION|1.939|Homo sapiens|0|transferase/transferase inhibitor","6OBB|JAK2 JH2 in complex with JAK170|X-RAY DIFFRACTION|1.904|Homo sapiens|0|transferase/transferase inhibitor","6OBF|JAK2 JH2 in complex with JAK179|X-RAY DIFFRACTION|1.71|Homo sapiens|0|transferase/transferase inhibitor","6OBL|JAK2 JH2 in complex with JAK168|X-RAY DIFFRACTION|2.061|Homo sapiens|0|transferase/transferase inhibitor","6OCC|JAK2 JH2 in complex with JAK190|X-RAY DIFFRACTION|2.03|Homo sapiens|0|transferase/transferase inhibitor","6TPD|Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity|X-RAY DIFFRACTION|1.99|Homo sapiens|0|TRANSFERASE","6VGL|JAK2 JH1 in complex with ruxolitinib|X-RAY DIFFRACTION|1.9|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","6VN8|JAK2 JH1 in complex with baricitinib|X-RAY DIFFRACTION|1.9|Homo sapiens|0|TRANSFERASE","6VNB|JAK2 JH1 in complex with BL2-084|X-RAY DIFFRACTION|2.19|Homo sapiens|0|TRANSFERASE","6VNC|JAK2 JH1 in complex with BL2-096|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE","6VNE|JAK2 JH1 in complex with Fedratinib|X-RAY DIFFRACTION|2.32|Homo sapiens|0|TRANSFERASE","6VNF|JAK2 JH1 in complex with MA9-086|X-RAY DIFFRACTION|2.06|Homo sapiens|0|TRANSFERASE"]}],"not_found":["Q9HC29"]}